Monoclonal antibodies: potential applications to the treatment of cancer.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000920:Antibody-Dependent Cell Cytotoxicity; D000951:Antigens, Neoplasm / Q000276:immunology; D016026:Bone Marrow Transplantation; D002272:Carcinoembryonic Antigen / Q000276:immunology; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000628:therapy; D006133:Growth Substances / Q000276:immunology; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000276:immunology; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012276:Ricin / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D006133:Growth Substances; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D012276:Ricin